摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-EtPhe(4-F)-NH2 | 78981-74-5

中文名称
——
中文别名
——
英文名称
N-EtPhe(4-F)-NH2
英文别名
(2S)-2-(ethylamino)-3-(4-fluorophenyl)propanamide
N-EtPhe(4-F)-NH2化学式
CAS
78981-74-5
化学式
C11H15FN2O
mdl
——
分子量
210.251
InChiKey
LIZUVCPFZKSVHR-JTQLQIEISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    117.5-118.5 °C(Solvent: Diethyl ether)
  • 沸点:
    369.8±37.0 °C(Predicted)
  • 密度:
    1.130±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    55.1
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-EtPhe(4-F)-NH2N-甲基吗啉盐酸1-羟基苯并三唑溶剂黄146苯甲醚三乙胺N,N'-二环己基碳二亚胺 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 81.0h, 生成 (R)-5-Guanidino-2-[(S)-2-guanidino-3-(4-hydroxy-phenyl)-propionylamino]-pentanoic acid ({[(S)-1-carbamoyl-2-(4-fluoro-phenyl)-ethyl]-ethyl-carbamoyl}-methyl)-amide; compound with acetic acid
    参考文献:
    名称:
    Peripherally acting enkephalin analogs. 2. Polar tri- and tetrapeptides
    摘要:
    The design, synthesis, and biological activity of a series of D-Arg2-enkephalin-derived tetrapeptide amides and tripeptide aralkylamides are reported. These polar analogues were designed to be excluded from the central nervous system with their action thus limited to peripheral opioid receptors. The effects of the nature of the aromatic ring, aryl ring substitution, and aralkylamine chain length on activity were investigated; in a number of cases the N-terminal amino group of Tyr1 was converted to a guanidino group to further increase hydrophilicity. The peptides were all synthesized by classical solution methodology. The opioid activity of the peptides was assessed in vitro on the guinea pig ileum and their antinociceptive activity was determined in vivo in chemically induced writhing models (peripheral activity) and in the hot-plate test (central activity), in rodents. That the analgesic effects were predominantly mediated in the periphery was demonstrated by antagonism of antinociception by the peripheral opioid antagonist N-methylnalorphine and by comparison of the activities in the writhing and hot-plate tests. As a class, the tetrapeptides were more potent than the tripeptides; N alpha-amidination generally increased activity. A number of compounds exhibited very potent opioid activity and had the desired pharmacological profile, indicating a high degree of peripheral selectivity.
    DOI:
    10.1021/jm00125a028
  • 作为产物:
    描述:
    BOC-L-4-氟苯丙氨酸N-甲基吗啉盐酸碳酸氢钠溶剂黄146苯甲醚氯甲酸异丁酯 作用下, 以 乙醇 为溶剂, 反应 8.08h, 生成 N-EtPhe(4-F)-NH2
    参考文献:
    名称:
    Peripherally acting enkephalin analogs. 2. Polar tri- and tetrapeptides
    摘要:
    The design, synthesis, and biological activity of a series of D-Arg2-enkephalin-derived tetrapeptide amides and tripeptide aralkylamides are reported. These polar analogues were designed to be excluded from the central nervous system with their action thus limited to peripheral opioid receptors. The effects of the nature of the aromatic ring, aryl ring substitution, and aralkylamine chain length on activity were investigated; in a number of cases the N-terminal amino group of Tyr1 was converted to a guanidino group to further increase hydrophilicity. The peptides were all synthesized by classical solution methodology. The opioid activity of the peptides was assessed in vitro on the guinea pig ileum and their antinociceptive activity was determined in vivo in chemically induced writhing models (peripheral activity) and in the hot-plate test (central activity), in rodents. That the analgesic effects were predominantly mediated in the periphery was demonstrated by antagonism of antinociception by the peripheral opioid antagonist N-methylnalorphine and by comparison of the activities in the writhing and hot-plate tests. As a class, the tetrapeptides were more potent than the tripeptides; N alpha-amidination generally increased activity. A number of compounds exhibited very potent opioid activity and had the desired pharmacological profile, indicating a high degree of peripheral selectivity.
    DOI:
    10.1021/jm00125a028
点击查看最新优质反应信息

文献信息

  • Study of intramolecular aminolysis in peptides containing N-alkylamino acids at position 2
    作者:Vladimir V. Ryakhovsky、Andrey S. Ivanov
    DOI:10.1016/j.tet.2012.06.056
    日期:2012.9
    IA more strongly than aqueous ammonia, while tertiary amines were less effective. Peptides with methionine-S-oxide residues were more labile than the unoxidized analogs, suggesting intramolecular assistance of the S-oxide group in aminolysis. Surprisingly, intermediate compounds of the formula Boc–Met-MeXaa-Sar–NHR underwent rapid cleavage (endopeptolysis) upon attempted acidolytic deprotection.
    许多肽和蛋白质,含Ñ α -烷基氨基酸(包括脯氨酸)在所述第二位置,很容易发生分子内氨解(IA)具有N-末端二肽序列的消除2,5-二酮哌嗪(DKP)。我们合成了一系列短肽,在2位含有N-烷基氨基酸,并研究了它们在乙酸和胺存在下的稳定性。在第二侧链和第三个氨基酸残基,并且烷基化在存在Ñ α第三氨基酸残基的减慢IA。ñ α-第一个氨基酸残基中的烷基残基仅在包含三个或更多个残基的肽中阻碍IA。第一个氨基酸的侧链没有显着影响裂解率。乙酸比氨水对IA的促进作用更强,而叔胺的效果较差。具有蛋氨酸-S-氧化物残基的肽比未氧化的类似物更不稳定,这表明在氨解中S-氧化物基团的分子内辅助。出人意料的是,式Boc–Met-MeXaa-Sar–NHR的中间体化合物在尝试进行酸解脱保护后迅速裂解(内肽水解)。
  • Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them
    申请人:ELI LILLY AND COMPANY
    公开号:EP0030845A2
    公开(公告)日:1981-06-24
    Compounds of the formula and pharmaceutically acceptable non-toxic acid addition salts thereof, in which Land D define the chirality; R1 is hydrogen or C1-C3 primary alkyl; R2 is C1-C4 primary or secondary alkyl, allyl, cyclopropylmethyl, C1-C2 hydroxyalkyl, or -(CH2)m-U-CH3 in which U is -S- or S-0 and mis 1 or 2; R3 is hydrogen, C1-C4 primary or secondary alkyl, cyclopropylmethyl, allyl or propargyl; and in which R, is hydrogen, acetyl, or acetoxymethyl and R5 is C1-C3 alkyl; are useful analgesic agents. These compounds are prepared by deblocking the correspondingly blocked compound of formula I with a deblocking agent.
    式化合物 及其药学上可接受的无毒酸加成盐,其中 Land D 定义了手性; R1 是氢或 C1-C3 伯烷基; R2 是 C1-C4 伯烷基或仲烷基、 烯丙基、环丙基甲基、C1-C2 羟基烷基或-(CH2)m-U-CH3,其中 U 是-S-或 S-0 且误为 1 或 2;R3 是氢、C1-C4 伯或仲烷基、环丙基甲基、烯丙基或丙炔基;以及 其中 R,是氢、乙酰基或乙酰氧甲基,R5 是 C1-C3 烷基;这些都是有用的镇痛剂。这些化合物的制备方法是用解嵌剂对相应的式 I 嵌段化合物进行解嵌。
  • HARDY, GEORGE W.;LOWE, LAWRENCE A.;MILLS, GAIL;PANG, YIH SANG;SIMPKIN, DE+, J. MED. CHEM., 32,(1989) N, C. 1108-1118
    作者:HARDY, GEORGE W.、LOWE, LAWRENCE A.、MILLS, GAIL、PANG, YIH SANG、SIMPKIN, DE+
    DOI:——
    日期:——
  • Peripherally acting enkephalin analogs. 2. Polar tri- and tetrapeptides
    作者:George W. Hardy、Lawrence A. Lowe、Gail Mills、Pang Yih Sang、Dean S. A. Simpkin、Rhonda L. Follenfant、Clare Shankley、Terence W. Smith
    DOI:10.1021/jm00125a028
    日期:1989.5
    The design, synthesis, and biological activity of a series of D-Arg2-enkephalin-derived tetrapeptide amides and tripeptide aralkylamides are reported. These polar analogues were designed to be excluded from the central nervous system with their action thus limited to peripheral opioid receptors. The effects of the nature of the aromatic ring, aryl ring substitution, and aralkylamine chain length on activity were investigated; in a number of cases the N-terminal amino group of Tyr1 was converted to a guanidino group to further increase hydrophilicity. The peptides were all synthesized by classical solution methodology. The opioid activity of the peptides was assessed in vitro on the guinea pig ileum and their antinociceptive activity was determined in vivo in chemically induced writhing models (peripheral activity) and in the hot-plate test (central activity), in rodents. That the analgesic effects were predominantly mediated in the periphery was demonstrated by antagonism of antinociception by the peripheral opioid antagonist N-methylnalorphine and by comparison of the activities in the writhing and hot-plate tests. As a class, the tetrapeptides were more potent than the tripeptides; N alpha-amidination generally increased activity. A number of compounds exhibited very potent opioid activity and had the desired pharmacological profile, indicating a high degree of peripheral selectivity.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物